title: Obesity and psychotropics.
abstract: Weight gain is on the rise in the United States as is the diagnosis and treatment of mental disorders. These two phenomena are distinctly separate but tend to overlap in that most psychotropic agents approved for use in the United States are associated with the potential to induce weight gain. Metabolic disorders such as diabetes, hypercholesterolemia, and hypertension are also on the rise and often associated with weight gain and clearly associated with certain psychotropic medications. This article serves to provide a succinct review regarding the epidemiology, etiology, and treatment options for psychotropic-induced obesity.
authors: SUNY Upstate Medical University, NY, USA.
authors: Nikhil
authors: N
authors: Nihalani
authors: Thomas L
authors: TL
authors: Schwartz
authors: Umar A
authors: UA
authors: Siddiqui
authors: James L
authors: JL
authors: Megna
mesh_terms: D001835:Body Weight / Q000187:drug effects; D006801:Humans; D008659:Metabolic Diseases / Q000139:chemically induced*; D009765:Obesity / Q000139:chemically induced* / Q000453:epidemiology*; D011619:Psychotropic Drugs / Q000009:adverse effects*; D014481:United States / Q000453:epidemiology
chemical_list: D011619:Psychotropic Drugs